Cancer - Prostate
Prostate cancer is a disease in which cancer develops in the prostate, a gland in the male reproductive system. Cancer occurs when cells of the prostate mutate and begin to multiply out of control. These cells may spread from the prostate to other parts of the body, especially the bones and lymph nodes. Prostate cancer may cause pain, difficulty in urinating, erectile dysfunction and other symptoms.
Rates of prostate cancer vary widely across the world. Although the rates vary widely between countries, it is least common in South and East Asia, more common in Europe, and most common in the United States. According to the American Cancer Society, prostate cancer is least common among Asian men and most common among black men with figures for European men in-between. However, these high rates may be affected by increasing rates of detection.
Prostate cancer develops most frequently in men over fifty. This cancer can occur only in men, as the prostate is exclusively of the male reproductive tract. It is the most common type of cancer in men in the United States, where it is responsible for more male deaths than any other cancer, except lung cancer. However, many men who develop prostate cancer never have symptoms, undergo no therapy, and eventually die of other causes. Many factors, including genetics and diet, have been implicated in the development of prostate cancer.
Prostate cancer is most often discovered by physical examination or by screening blood tests, such as the PSA (prostate specific antigen) test. There is some current concern about the accuracy of the PSA test and its usefulness. Suspected prostate cancer is typically confirmed by removing a piece of the prostate and examining it under a microscope. Further tests, such as X-rays and bone scans, may be performed to determine whether prostate cancer has spread.
Prostate cancer can be treated with surgery, radiation therapy, hormone therapy, occasionally chemotherapy, or some combination of these. The age and underlying health of the man as well as the extent of spread, appearance under the microscope, and response of the cancer to initial treatment are important in determining the outcome of the disease. Since prostate cancer is a disease of older men, many will die of other causes before the prostate cancer can spread or cause symptoms. This makes treatment selection difficult. The decision whether or not to treat localized prostate cancer with curative intent is a patient trade-off between the expected beneficial and harmful effects in terms of patient survival and quality of life.
...More at Wikipedia
Related Links:
Cancer - Prostate
Questions recently asked by other users
- Link between prostate and kidney cancer
Have there been any studies linking prostate and kidney cancer ?
Asked By: [Touch57]
[See or Give An Answer]
Latest Cancer / Oncology News From Medical News Today.
- Bovie Medical Corporation Announces FDA 510(K) Clearance To Market SEER Tissue Resection Device
- Randomized Phase 2 Study Of IMC-A12 For HER2-Expressing Advanced Breast Cancer Commences Patient Enrollment
- GenVec Announces Interim Survival Data In Pivotal Trial Of TNFerade™ In Locally Advanced Pancreatic Cancer
- Relapsed Ovarian Cancer - Submitted New Drug Application To FDA For Trabectedin
- Higher Risk Of Certain Cancers Being Recorded In HIV-Positive People
- Ovarian Cancer Cells Destroyed By New Platinum-Phosphate Compounds
- Gentium Provides An Update On The Phase 3 Treatment Trial Of Defibrotide For Severe Veno-Occlusive Disease
- Lymphoma Association Launches New Short Film
- New Imaging Technique Tracks Cancer-Killing Cells Over Prolonged Period In First-Ever Stanford Case Study
- Survival Of Head And Neck Cancer Patients Is Greatly Affected By Coexisting Ailments
- Common Virus Helps Quality Of Life For Sarcoma Patients Says Cancer Expert
